The largest database of trusted experimental protocols

6 protocols using bexarotene

1

Bexarotene Administration in C57BL/6 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old C57BL/6 male mice were purchased from Beijing Vitalstar Biotechnology (Beijing, China). Mice were housed on a 12 h light-dark cycle at 21–25 °C with 30–70% humidity and allowed free access to food and water except as noted. Mice were randomly assigned to experimental groups. For the bexarotene experiment, eight-week-old mice were orally gavaged daily with 100 mg/kg/day of bexarotene (S2098, Selleck) or 10% DMSO/90% corn oil vehicle three days before the procedure. The mice continued to be treated with bexarotene daily for two days after injury.
+ Open protocol
+ Expand
2

Therapeutic Compounds for Post-SAH Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug preparation and administration were previously described by Zhong et al.28 (link) Briefly, 20 mg bexarotene (Selleck, Shanghai, China) was dissolved in 5.7 ml
dimethyl sulfoxide (DMSO), and 51.3 ml phosphate-buffered saline (PBS) was added to the
mixture. Similarly, 10 mg GW9662 (Selleck), an inhibitor of PPARγ was dissolved in 3.6 ml
DMSO, and PBS (32.4 ml) was added to the mixture. A total of 10 mg of MK886 (Selleck), an
antagonist of FLAP was dissolved in 2.1 ml DMSO, and 18.9 ml PBS was added to the mixture.
The final concentrations of GW9662, MK886 and bexarotene were the same (1 mM). The
solution was injected intraperitoneally at 5 mg/kg bexarotene, 2 mg/kg GW9662, and 3 mg/kg
MK886 per day after SAH. The vehicle group solution was prepared in the same manner and
administered in the same volume, same route and same time course as above. These reagents
were used immediately after SAH and continued to be used once a day until the rats were
euthanized.
+ Open protocol
+ Expand
3

Retinoid Compound Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATRA (Sigma-Aldrich, Milwaukee, WI, USA), AM80 (Tocris, Ellisville, MS, USA), and bexarotene (Selleck Chemicals, Houston, TX, USA) were dissolved in dimethyl sulfoxide and stock solutions and stored at −80°C. Retinoids were protected from light during handling.
+ Open protocol
+ Expand
4

Culturing Pituitary Corticotroph Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse anterior pituitary corticotroph adenoma cell line AtT‐20/D16v‐F2 was purchased from ATCC, while COS‐7 cell line was purchased from Cell Bank of Type Culture Collection of Chinese Academy of Sciences. AtT‐20 cells and COS‐7 cells were cultured in DMEM (ATCC, 30‐2002) media supplemented with 10% foetal bovine serum (Cellmax, Peking, China) and penicillin‐streptomycin. The cells were incubated at 37°C and 5% CO2 atmosphere. Bexarotene, ATRA, and dexamethasone (DEX) were obtained from Selleck and stored at −80°C. Corticotropin‐releasing factor human (CRH) was obtained from MCE and stored at −80°C.
+ Open protocol
+ Expand
5

Bexarotene Attenuates SAH Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bexarotene (Selleck Chemicals, Houston, USA) was diluted in 10% dimethyl sulfoxide (DMSO). Administered 1 h after SAH by i.p injection, three different doses (5 mg/kg, 15 mg/kg, and 45 mg/kg) were evaluated. The SAH + vehicle group received an equal volume of 10% DMSO. The RXR inhibitor UVI3003 (75 μg/rat, Sigma-Aldrich, St. Louis, MO) or selective SIRT6 antagonist OSS128167 (100 μg/rat, Selleck Chemicals, Houston, TX) dissolved in 10% DMSO was injected by i.c.v route at 1 h before SAH. The same volume of 10% DMSO was injected via i.c.v in SAH + Bexa + vehicle group.
+ Open protocol
+ Expand
6

Adipogenic Differentiation Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alitretinoin was bought from Santa Cruz Biotechnology (Santa Cruz, CA). Bexarotene and heparin sodium were purchased from Selleck Chemicals (Houston, TX, USA). UVI3003, dexamethasone (DEX), 3-isobutyl-1-methylxanthine (IBMX), and insulin were obtained from Sigma Company (Sigma-Aldrich, St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!